HIPAA Alert: Potential Data Breach Learn More

Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic

844-346-7222
Search
Close this search box.
844-346-7222
REQUEST AN APPOINTMENT

Gynecologic

Gynecologic

We’re here for you. Call us at 844-346-7222 or

request an appointment online

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

7 Clinical Trials
Gynecologic Phase I/II Accepting Patients
nct/study# NCT03393884 / 201-17-201

A Phase I/II Study Evaluating The Dosing, Safety, Efficacy, And Biological Activity Of Intraperitoneal GEN-1 (IL-12 Plasmid Formulated With PEG-PEI-Cholesterol Lipopolymer) Administered In Combination With Neoadjuvant Chemotherapy (NACT) In Patients Actively Diagnosed With Advanced Epithelial Ovarian, Fallopian Tube Or Primary Peritoneal Cancer

Learn More
Gynecologic Phase I Accepting Patients
nct/study# NCT03704467 / RESEARCH-DEVELOPMENT-MS201943-0029

A Phase Ib Safety Run-In And Randomized Phase II, Open-Label Study To Evaluate The Efficacy, Safety, Tolerability, And Pharmacokinetics Of M6620 In Combination With Avelumab And Carboplatin In Comparison To Standard Of Care Therapy In Participants With Parpi-Resistant Recurrent Ovarian, Primary Peritoneal, Or Fallopian Tube Cancer

Learn More
Gynecologic Phase III Accepting Patients
nct/study# NCT02466971 / NRG-ONCOLOGY-GY006

A Randomized Phase II Trial Of Radiation Therapy And Cisplatin Alone Or In Combination With Intravenous Triapine In Women With Actively Diagnosed Bulky Stage IB2, Stage II, IIIB, Or IVA Cancer Of The Uterine Cervix Or Stage II-IVA Vaginal Cancer

Learn More
Gynecologic Phase III Accepting Patients
nct/study# NCT00980954 / RTOG-0724-0724

Phase III Randomized Study Of Concurrent Chemotherapy And Pelvic Radiation Therapy With Or Without Adjuvant Chemotherapy In High-Risk Patients With Early-Stage Cervical Carcinoma Following Radical Hysterectomy

Learn More
Gynecologic Phase III Active
nct/study# NA / MK3475-B96

A Phase 3, Randomized, Double-Blind Study Of Pembrolizumab Versus Placebo In Combination With Paclitaxel With Or Without Bevacizumab For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer (KEYNOTE-B96 / ENGOT-Ov65)

Learn More
Gynecologic Phase III Active
nct/study# NCT04095364 / NRG-GY019

A Randomized Phase III, Two-Arm Trial Of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy In Patients With Stage II-IV, Primary Low-Grade Serous Carcinoma Of The Ovary Or Peritoneum

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Request An Appointment
Community Oncology Alliance Logo
COA Patient Advocacy Network Logo
OncLive® Strategic Alliance Partner Badge
Pharmacy Times® Strategic Alliance Partner Badge
Targeted Oncology Strategic Alliance Partner Badge

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.